Headlands Technologies »

Travere Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 2.6k 8.99

More positions owned by Headlands Technologies

Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Pepsi (PEP)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Workday Cl A (WDAY)
Citigroup Com New (C)
Icici Bank Adr (IBN)
Synopsys (SNPS)
Meta Platforms Cl A (META)

View all positions for Headlands Technologies

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics